ViewRay’s MRIdian® to be Featured at Leading European Radiation Oncology Meeting

50 clinical presentations and posters highlight benefits of MRI-guided radiation adaptive therapy DENVER, May 12, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) announced today that the company’s MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the…